Cassava Sciences Inc. Securities Fraud Class Action Lawsuit Update: Contact Levi …
Cassava Sciences, Inc. is currently facing a securities fraud class action lawsuit. Investors are encouraged to reach out to Levi & Korsinsky before February 10, 2025, to discuss the details of the case.
The lawsuit alleges that Cassava Sciences made false and misleading statements regarding its Alzheimer’s drug, causing harm to investors. If you are an investor in Cassava Sciences, it is important to be informed about the situation and understand your options.
It’s always a good idea to stay updated on any legal matters that may impact your investments. By reaching out to Levi & Korsinsky, you can gain a better understanding of the allegations against Cassava Sciences and how they may affect you as an investor.
Remember, staying informed and seeking legal advice when necessary is key to protecting your investments. Don’t hesitate to reach out to Levi & Korsinsky before the deadline on February 10, 2025, to discuss the securities fraud class action lawsuit involving Cassava Sciences, Inc.